City
Epaper

Indigenous COVID vaccine demonstrates benefits of Atmanirbhar Bharat, asserts Vice President

By ANI | Published: January 04, 2021 5:22 PM

A day after the Drugs Controller General of India (DCGI) gave its nod for the emergency use approval for two indigenous vaccines against COVID-19 on Sunday, Vice President M Venkaiah Naidu on Monday termed it as India's leap of science and manifestation of the spirit of Atmanirbhar Bharat.

Open in App

A day after the Drugs Controller General of India (DCGI) gave its nod for the emergency use approval for two indigenous vaccines against COVID-19 on Sunday, Vice President M Venkaiah Naidu on Monday termed it as India's leap of science and mfestation of the spirit of Atmrbhar Bharat.

Naidu, as quoted in a release from Vice President's Secretariat, stressed that this development can benefit not only Indians but the larger humty. He also appealed the people to express same spirit in taking the vaccine as they did while persevering through the coronavirus pandemic in 2020.

"India is in the forefront of shielding the humty from the deadly disease by demonstrating its ability to mass produce the much-needed vaccine and offer its own version as well. India's indigenous vaccine (Covaxin) has certain unique features based on the whole virus approach. This is a commendable achievement and all concerned deserve kudos for foresight perseverance and fruition of spirited efforts," the release read.

Referring to the devastating effects of COVID-19 in preceding year, Naidu hailed the spirited scientific efforts to come out with vaccines.

He further said, "While the celebrations can wait till every needy person gets the vaccine shot, it's not out of context to say cheers to this optimistic moment."

He noted that India's spirited efforts towards making vaccines available offers hope to people across the globe conferring on India the leadership role in the collective fight against the most dreaded health challenge of the last 100 years since the outbreak of Spsh Flu.

Noting that development and administering of vaccine is guided by a stringent regime of protocols and strict monitoring of attendant data without any compromise, the Vice President referred to the regulator's assurance to the nation of due diligence before giving nod to the two vaccines, Covishield and Covaxin yesterday.

"India's leap of science with the vaccine announcement is a clear mfestation of the spirit of Atma Nirbhar Bharat. It demonstrates what a self-reliant India means not only to its people but also to the rest of the world. India standing tall at this critical moment is one of great reckoning. It vindicates our ethos of sharing with and caring for all. The soon to start vaccine roll out is a certain beginning towards leaving the miseries and anxieties of the last year behind," the release stated.

Naidu observed that the country rose in unison in 2020 in handling the COVID situation with the national leadership both in the Centre and in the States/Union Territories (UTs) working together.

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

Other SportsFIFA WC Joint Qualifiers: Inter Kashi’s Lalrindka impresses in first national camp ahead of key clash

National'Bulawa Tolis' to be activated in booths with low voting percentages in UP

EntertainmentNaomi Campbell revives her 1997 Chanel dress for Cannes red carpet

Other SportsPara shuttler Sukant Kadam qualifies for Paris Paralympics

EntertainmentHighly Anticipated Big Ticket OTT Show Sequels Coming in Late 2024

National Realted Stories

NationalLabourer from Jharkhand shot dead, two others injured in Manipur attack

NationalBengal CM has crossed all limits by maligning saints of iconic institutions: PM Modi

NationalPeople of Punjab benefited from Centre's funds: State BJP chief Jakhar

National328 LS candidates allotted election symbols in Punjab: CEO

NationalPMK leader urges TN govt to procure paddy at Rs 3,000 per quintal